================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
August 9, 2002
BOSTON SCIENTIFIC CORPORATION
------------------------------------------
(Exact Name of Registrant as Specified in Charter)
DELAWARE 1-11083 04-2695240
-------- ------- ----------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
One Boston Scientific Place, Natick, Massachusetts 01760
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (508) 650-8000
--------------
================================================================================
ITEM 9. REGULATION FD DISCLOSURE.
Pursuant to Commission Order No. 4-460, the Chief Executive Officer
and Chief Financial Officer of Boston Scientific Corporation each delivered to
the Commission on August 9, 2002 statements under oath regarding facts and
circumstances relating to certain of Boston Scientific Corporation's Exchange
Act filings. The statements are attached as Exhibits 99.1 and 99.2 hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BOSTON SCIENTIFIC CORPORATION
By: /s/ Lawrence J. Knopf
---------------------------------------------
Lawrence J. Knopf
Vice President and Assistant General Counsel
Dated: August 9, 2002
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Statement Under Oath of Principal Executive Officer of Boston
Scientific Corporation Regarding Facts and Circumstances Relating to
Exchange Act Filings
99.2 Statement Under Oath of Principal Financial Officer of Boston
Scientific Corporation Regarding Facts and Circumstances Relating to
Exchange Act Filings